Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine 1st Edition Emilija Veljkovic – Ebook PDF Instant Download/Delivery: 0128129239, 9780128129234
Full dowload Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine 1st Edition after payment

Product details:
ISBN 10: 0128129239
ISBN 13: 9780128129234
Author: Emilija Veljkovic; Wenhao Xia; Blaine Phillips; Ee Tsin Wong; Jenny Ho; Alberto Oviedo Casado; Julia
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer’s disease, Parkinson’s disease, Multiple Sclerosis, Tourette’s syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually.
This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers.
By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development.
- Presents the first comprehensive, tabulated summary of literature on the epidemiological data on smoking and neurological disease
- Includes preclinical and clinical data on nicotine in neurological diseases and mechanisms of action of nicotine in neuroprotection
- Features a comprehensive summary of non-nicotine smoke constituents with potentially neuroprotective and anti-inflammatory properties
- Discusses Multiple Sclerosis, Alzheimer’s disease, Parkinson’s Disease, Schizophrenia, Depression, ADHD, Anxiety and Tourette’s Syndrome in the context of smoking and nicotine
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine 1st Table of contents:
Part I: Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine
Chapter 1: Parkinson’s Disease
Abstract
1.1 Symptoms and Epidemiology
1.2 Molecular Mechanisms
1.3 Impact of Smoking, Snus, and Nicotine
Chapter 2: Alzheimer’s Disease
Abstract
2.1 Symptoms and Epidemiology
2.2 Molecular Mechanisms
2.3 Impact of Smoking and Nicotine
Chapter 3: Multiple Sclerosis
Abstract
3.1 Symptoms and Epidemiology
3.2 Molecular Mechanisms
3.3 Impact of Smoking, Snus, and Nicotine
Chapter 4: Schizophrenia
Abstract
4.1 Symptoms and Epidemiology
4.2 Molecular Mechanisms
4.3 Impact of Smoking and Nicotine
Chapter 5: Tourette Syndrome
Abstract
5.1 Symptoms, Epidemiology, and Potential Causes
5.2 Impact of Smoking and Nicotine
Chapter 6: Attention Deficit Hyperactivity Disorder in Children and Adults
Abstract
6.1 Symptoms, Epidemiology, and Potential Causes
6.2 Impact of Smoking and Nicotine
Chapter 7: Depression
Abstract
7.1 Symptoms, Epidemiology, and Potential Causes
7.2 Impact of Smoking and Nicotine
Chapter 8: Anxiety
Abstract
8.1 Symptoms, Epidemiology, and Potential Causes
8.2 Impact of Smoking and Nicotine
Part II: Overview of the Pharmacology of Nicotine and Other Tobacco-Derived Compounds
Chapter 9: Nicotine
Abstract
9.1 Pharmacological Considerations
9.2 Impact of Nicotine on Brain Development
9.3 nAChR Agonists
Chapter 10: Other Compounds From Tobacco With Potential Impact on Neurodegenerative Diseases
Abstract
10.1 Monoamine Oxidase Inhibitors for Neurodegenerative Disease Therapy
10.2 Other Tobacco Compounds and Neuroprotection
Chapter 11: Research Models of Neurodegenerative Diseases: Major Considerations for Translatability
Abstract
Chapter 12: Concluding Remarks
Abbreviations
References
Index
People also search for Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases Overview of Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine 1st:
is nicotine added to tobacco
is nicotine added to tobacco in cigarettes
nicotine sources other than tobacco
does nicotine grow in tobacco